[Federal Register Volume 61, Number 176 (Tuesday, September 10, 1996)]
[Notices]
[Pages 47756-47757]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-22996]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


Alternative Medicine Program Advisory Council; Notice of Meeting

    Pursuant to sec. 10(d) of the Federal Advisory Committee Act 
(FACA), as amended (Title 5, U.S.C. Appendix 2), notice is hereby given 
of the meeting of the Alternative Medicine Program Advisory Council on 
September 16, 1996 from 8:30 am to 5 pm and on September 17 from 8:30 
am to 1 pm in the Versailles II Room of the Holiday Inn, 8120 Wisconsin 
Avenue, Bethesda, Maryland.
    The entire meeting will be open to the public. The purpose of the 
meeting will be to update the Council on the progress of the Office of 
Alternative Medicine and obtain Council's advice on strategic planning 
for complementary and alternative medicine research. There will also be 
a scientific presentation, ``Shifting Paradigms in Growth Factor/
Cytokine Biotechnology: The Science, the Paradigm, the Interface,'' by 
Barbara Brewitt, M.Div., Ph.D., Chief Scientist, Biomed Comm, Inc. and 
Leana Standish, N.D., Ph.D., Research Director, CAM Research Center, 
Bastyr University. Attendance by the public will be limited to space 
available.
    Ms. Elizabeth Clay, Committee Management Officer, Office of 
Alternative Medicine, NIH, 9000 Rockville Pike, Building 31, Room 5B37, 
MSC 2182 Bethesda, MD 20892, phone (301) 594-1990, fax (301) 402-4741, 
E-Mail: [email protected], will furnish the meeting agenda, roster 
of committee members, and substantive program information upon request. 
Any individual who requires special assistance, such as sign language 
interpretation or other reasonable accommodations, should contact Ms. 
Clay at the above location no later than September 11, 1996.
    This notice is being published less than 15 days prior to the 
meeting due

[[Page 47757]]

to the urgent need to proceed with the meeting as scheduled in order to 
address these issues in a timely manner.

    Dated: August 30, 1996.
Margery G. Grubb,
Senior Committee Management Specialist, NIH.
[FR Doc. 96-22996 Filed 9-9-96; 8:45 am]
BILLING CODE 4140-01-M